These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 27644251)
41. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma. Li C; Zhao Z; Zhou Z; Liu R Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118 [TBL] [Abstract][Full Text] [Related]
42. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949 [TBL] [Abstract][Full Text] [Related]
43. Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies. Bahr BL; Price MD; Merrill D; Mejia C; Call L; Bearss D; Arroyo J Placenta; 2014 Nov; 35(11):883-90. PubMed ID: 25260566 [TBL] [Abstract][Full Text] [Related]
44. Targeting PKM2 promotes chemosensitivity of breast cancer cells in vitro and in vivo. Wang Y; Zhao H; Zhao P; Wang X Cancer Biomark; 2021; 32(2):221-230. PubMed ID: 34092620 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer. Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555 [TBL] [Abstract][Full Text] [Related]
46. Significant association of PKM2 and NQO1 proteins with poor prognosis in breast cancer. Zhu K; Li Y; Deng C; Wang Y; Piao J; Lin Z; Chen L Pathol Res Pract; 2020 Nov; 216(11):153173. PubMed ID: 32841776 [TBL] [Abstract][Full Text] [Related]
47. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599 [TBL] [Abstract][Full Text] [Related]
48. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis. Zhao C; Li H; Wang L; Sun W Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496 [TBL] [Abstract][Full Text] [Related]
49. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis. Pu F; Liu J; Jing D; Chen F; Huang X; Shi D; Wu W; Lin H; Zhao L; Zhang Z; Lv X; Wang B; Zhang Z; Shao Z Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244192 [TBL] [Abstract][Full Text] [Related]
50. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis. Zhu H; Cai H; Tang M; Tang J Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507 [TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2. Meoli L; Gupta NK; Saeidi N; Panciotti CA; Biddinger SB; Corey KE; Stylopoulos N Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E613-E621. PubMed ID: 29462566 [TBL] [Abstract][Full Text] [Related]
52. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer. Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677 [TBL] [Abstract][Full Text] [Related]
53. Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis. Abd El-Rehim DM; Osman NA J Egypt Natl Canc Inst; 2015 Mar; 27(1):1-9. PubMed ID: 25481287 [TBL] [Abstract][Full Text] [Related]
54. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer. Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603 [TBL] [Abstract][Full Text] [Related]
55. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma. Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774 [TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma. Li F; Cao L; Hang D; Wang F; Wang Q Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868 [TBL] [Abstract][Full Text] [Related]
57. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma. Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210 [TBL] [Abstract][Full Text] [Related]
58. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
59. Lack of Evidence for PKM2 Protein Kinase Activity. Hosios AM; Fiske BP; Gui DY; Vander Heiden MG Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261 [TBL] [Abstract][Full Text] [Related]
60. Src nuclear localization and its prognostic relevance in human osteosarcoma. Urciuoli E; Coletta I; Rizzuto E; De Vito R; Petrini S; D'Oria V; Pezzullo M; Milano GM; Cozza R; Locatelli F; Peruzzi B J Cell Physiol; 2018 Feb; 233(2):1658-1670. PubMed ID: 28671269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]